ReNeuron and StemCells get green light for neural stem cell trials

@article{Mack2011ReNeuronAS,
  title={ReNeuron and StemCells get green light for neural stem cell trials},
  author={George S. Mack},
  journal={Nature Biotechnology},
  year={2011},
  volume={29},
  pages={95-97}
}
95 to remain vital and propagate for manufacturing scale-up (BMC Neurosci. 10, 86, 2009). “It prolongs the lifespan of the cells and enables us to use cell lines in perpetuity without going back for new donor cells,” says John Sinden, CSO and cofounder of ReNeuron. “And it also allows us to clone out individual cell lines.” Once transplanted and removed from the effects of 4-hydroxytamoxifen, ReNeuron claims c-Myc expression is not only shut down but also silenced due to DNA methylation of the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

Neuroprotective Effects of Stem Cells in Ischemic Stroke

Stem cells international • 2017
View 2 Excerpts

Similar Papers

Loading similar papers…